What's new

Qualification opinion for artificial intelligence-based measurement of non-alcoholic steatohepatitis histology in liver biopsies to determine disease activity in NASH/MASH clinical trials

Qualification opinion for artificial intelligence-based measurement of non-alcoholic steatohepatitis histology in liver biopsies to determine disease activity in NASH/MASH clinical trials

Apr 22, 2025 - 14:30
 0
Qualification opinion for artificial intelligence-based measurement of non-alcoholic steatohepatitis histology in liver biopsies to determine disease activity in NASH/MASH clinical trials
Read More

Tags:

Previous Article

Hoshino Resorts Debuts Mountain Hotel Brand as Japan Tourism Surges

Next Article

H&M Group: Cos Expands Range with Fragrance Line

Related Posts

Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 13/11/2013, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 24, 2025  0

Human medicines European public assessment report (EPAR): Lynozyfic, linvoseltamab, Status: Opinion

Human medicines European public assessment report (EPAR...

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 26, 2025  0